Edmonton frail score is associated with diabetic control in elderly type 2 diabetic subjects

Basit Öğe Kaydı
dc.authorid0000-0003-2811-0052en_US
dc.authorid0000-0001-7306-5233en_US
dc.authorid0000-0002-3836-2125
dc.contributor.authorBilgin, Satılmış
dc.contributor.authorAktaş, Gülali
dc.contributor.authorKurtkulağı, Özge
dc.contributor.authorAtak, Burçin Meryem
dc.contributor.authorDuman, Tuba Taslamacıoğlu
dc.date.accessioned2021-06-23T19:54:14Z
dc.date.available2021-06-23T19:54:14Z
dc.date.issued2020
dc.departmentBAİBÜ, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümüen_US
dc.description.abstractPurpose We aimed to observe clinical and laboratory indices of the diabetic subjects who were either frail or not according to Edmonton frail score. We also aimed to study whether Edmonton frail score was correlated with metabolic and other parameters of the diabetic subjects. Methods Patients with T2DM visited our clinic were enrolled to the study and grouped as either frail or not frail according to the Edmonton score. Clinical and laboratory parameters of the groups were compared. Results Serum triglyceride (p = 0.04), serum albumin (p = 0.006) and Glomerular Filtration Rate (GFR) (p = 0.01) were significantly lower, while fasting blood glucose (FBG) (p = 0.02), HDL cholesterol (p = 0.005) and glycated hemoglobin (HbA1c) (p = 0.04) were significantly higher in frail group compared to the not frail patients. Edmonton frail score was positively correlated with HbA1c, age, duration of T2DM, FBG, and negatively correlated with serum albumin and GFR levels. Conclusions We think that frailty is associated with poor glucose control in subjects with T2DM and better control of the disease may prevent or slow down the development of frailty, as well as microvascular complications in subjects with type 2 diabetes mellitus.en_US
dc.identifier.doi10.1007/s40200-020-00542-z
dc.identifier.endpage514en_US
dc.identifier.issn2251-6581
dc.identifier.issue1en_US
dc.identifier.pmid32550203en_US
dc.identifier.scopus2-s2.0-85084589509en_US
dc.identifier.scopusqualityQ2en_US
dc.identifier.startpage511en_US
dc.identifier.urihttps://doi.org/10.1007/s40200-020-00542-z
dc.identifier.urihttps://hdl.handle.net/20.500.12491/10469
dc.identifier.volume19en_US
dc.identifier.wosWOS:000533250000001en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.institutionauthorAktaş, Gülali
dc.institutionauthorKurtkulağı, Özge
dc.institutionauthorAtak, Burçin Meryem
dc.institutionauthorDuman, Tuba Taslamacıoğlu
dc.institutionauthorBilgin, Satılmış
dc.language.isoenen_US
dc.publisherSpringer International Publishing Agen_US
dc.relation.ispartofJournal Of Diabetes And Metabolic Disordersen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectType 2 Diabetes Mellitusen_US
dc.subjectFrailtyen_US
dc.subjectHbA1cen_US
dc.subjectEdmonton Frail Scoreen_US
dc.titleEdmonton frail score is associated with diabetic control in elderly type 2 diabetic subjectsen_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
satilmis-bilgin.pdf
Boyut:
171.78 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin/Full Text
İndir

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
Dahili Tıp Bilimleri Bölümü Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu